Submucosal Lifting Agent Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

Description

The submucosal lifting agent market is poised for steady growth, fueled by the increasing demand for advanced gastrointestinal endoscopic procedures. The market is expected to reach USD 1.26 billion by 2025 and USD 2.07 billion by 2032, registering a CAGR of 7.39% during the forecast period. The growing incidence of gastrointestinal diseases and the preference for minimally invasive procedures are key factors propelling the adoption of submucosal lifting agents.

Market Analysis

Submucosal lifting agents play a vital role in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) by creating a safe separation between mucosal and submucosal layers. These agents enhance visibility, facilitate precise lesion removal, and reduce the risk of perforation, making them essential in gastroenterology. The submucosal lifting agent market is set to expand steadily, supported by technological innovations, an increasing disease burden, and the rising preference for minimally invasive procedures. Companies focusing on product development, regulatory adherence, and strategic partnerships will be well-positioned to leverage the growing demand for effective and safe lifting agents in gastrointestinal endoscopy.

Key Growth Drivers

Rising Gastrointestinal Disorders: The increasing incidence of colorectal tumors and early-stage gastrointestinal cancers is boosting the demand for submucosal lifting agents in diagnostic and therapeutic procedures.
Technological Innovations in Endoscopy: Advances in endoscopic devices and lifting agent formulations are improving the safety and efficiency of gastrointestinal interventions.
Surge in Minimally Invasive Techniques: The preference for less invasive treatments over traditional surgical approaches is driving market expansion.
Strict Regulatory Standards: Enhanced quality control and compliance measures are ensuring the safety and efficacy of emerging submucosal lifting agents, shaping market dynamics.

Business Prospects

Development of Advanced Formulations: Companies are investing in R&D to enhance the viscosity, duration, and effectiveness of lifting agents, creating new opportunities in the market.
Strategic Collaborations: Partnering with medical device manufacturers can facilitate the development of integrated solutions for endoscopic procedures.
Emerging Market Expansion: South Asia and the Pacific are projected to witness significant growth due to increased healthcare investments and a rising prevalence of gastrointestinal conditions.

Regional Outlook

Europe: Leading the market due to its advanced healthcare infrastructure and widespread adoption of endoscopic procedures.
South Asia & Pacific: The fastest-growing region, attributed to rising healthcare accessibility and a growing burden of gastrointestinal diseases.
North America: A key market with high demand for cutting-edge endoscopic interventions and strong industry presence.
Latin America, Middle East & Africa: Developing regions with increasing access to advanced endoscopic techniques.

Leading Companies

Top players in the submucosal lifting agent market include:

Laborie
STERIS
Olympus America
Medtronic
Boston Scientific Corporation
Omnimed Ltd(TM)
COSMO PHARMACEUTICALS
Micro-Tech Endoscopy
Ovesco Endoscopy AG

Recent Market Developments

Innovation by AscentX Medical: The company introduced a minimally invasive endoscopic injection method to treat conditions such as gastroesophageal reflux disease, highlighting advancements in the sector.
Boston Scientific's ORISE Gel Recall (October 2022): A recall raised industry concerns regarding product safety and regulatory compliance, emphasizing the need for stringent quality control measures.

Market Segmentation

By Ingredient: Sodium Hyaluronate, Poloxamers, Cellulose, Absorbable Starch Polymers, Poloxamer 188, and Polyoxyl-15-hydroxystearate.
By Type: Normal saline, Dextrose water, Hydroxypropyl methylcellulose, Hydroxyethyl starch, Hyaluronic acid, Fibrinogen mixture, Succinylated gelatin, Eleview, and ORISE gel.
By Application: Polyps, Adenomas, Early-stage Cancers, Gastrointestinal Mucosal Lesions, and Others.
By End-Use: Hospitals, Specialty Clinics, Surgical Centers, and Others.
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

1. Executive Summary

1.1. Global Submucosal Lifting Agent Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. PESTLE Analysis

3. Price Analysis, 2025

3.1. Global Average Price Analysis, by Ingredient/ Material, US$ Per Unit, 2025
3.2. Prominent Factor Affecting Submucosal Lifting Agent Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Submucosal Lifting Agent Market Outlook, 2019 - 2032

4.1. Global Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 4.1.1. Key Highlights
  - 4.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 4.1.1.2. Gellan gum and Polysaccharide
  - 4.1.1.3. Sodium Hyaluronate
  - 4.1.1.4. Cellulose
  - 4.1.1.5. Absorbable Starch Polymers
  - 4.1.1.6. Poloxamers
4.2. Global Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 4.2.1. Key Highlights
  - 4.2.1.1. Normal saline
  - 4.2.1.2. Dextrose water
  - 4.2.1.3. Hydroxypropyl methylcellulose
  - 4.2.1.4. Hydroxyethyl starch
  - 4.2.1.5. Hyaluronic acid
  - 4.2.1.6. Fibrinogen mixture
  - 4.2.1.7. Succinylated gelatin
  - 4.2.1.8. Eleview and ORISE gel
4.3. Global Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 4.3.1. Key Highlights
  - 4.3.1.1. Polyps
  - 4.3.1.2. Adenomas
  - 4.3.1.3. Early-stage Cancers
  - 4.3.1.4. Gastrointestinal Mucosal Lesions
  - 4.3.1.5. Others
4.4. Global Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 4.4.1. Key Highlights
  - 4.4.1.1. Hospitals
  - 4.4.1.2. Specialty Clinics
  - 4.4.1.3. Surgical Centers
  - 4.4.1.4. Others
4.5. Global Submucosal Lifting Agent Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 4.5.1. Key Highlights
  - 4.5.1.1. North America
  - 4.5.1.2. Europe
  - 4.5.1.3. Asia Pacific
  - 4.5.1.4. Latin America
  - 4.5.1.5. Middle East & Africa

5. North America Submucosal Lifting Agent Market Outlook, 2019 - 2032

5.1. North America Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 5.1.1. Key Highlights
  - 5.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 5.1.1.2. Gellan gum and Polysaccharide
  - 5.1.1.3. Sodium Hyaluronate
  - 5.1.1.4. Cellulose
  - 5.1.1.5. Absorbable Starch Polymers
  - 5.1.1.6. Poloxamers
5.2. North America Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 5.2.1. Key Highlights
  - 5.2.1.1. Normal saline
  - 5.2.1.2. Dextrose water
  - 5.2.1.3. Hydroxypropyl methylcellulose
  - 5.2.1.4. Hydroxyethyl starch
  - 5.2.1.5. Hyaluronic acid
  - 5.2.1.6. Fibrinogen mixture
  - 5.2.1.7. Succinylated gelatin
  - 5.2.1.8. Eleview and ORISE gel
5.3. North America Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 5.3.1. Key Highlights
  - 5.3.1.1. Polyps
  - 5.3.1.2. Adenomas
  - 5.3.1.3. Early-stage Cancers
  - 5.3.1.4. Gastrointestinal Mucosal Lesions
  - 5.3.1.5. Others
5.4. North America Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Specialty Clinics
  - 5.4.1.3. Surgical Centers
  - 5.4.1.4. Others
5.5. North America Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 5.5.1. Key Highlights
  - 5.5.1.1. U.S. Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.2. U.S. Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.3. U.S. Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.4. U.S. Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.5. Canada Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.6. Canada Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.7. Canada Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 5.5.1.8. Canada Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Submucosal Lifting Agent Market Outlook, 2019 - 2032

6.1. Europe Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 6.1.1. Key Highlights
  - 6.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 6.1.1.2. Gellan gum and Polysaccharide
  - 6.1.1.3. Sodium Hyaluronate
  - 6.1.1.4. Cellulose
  - 6.1.1.5. Absorbable Starch Polymers
  - 6.1.1.6. Poloxamers
6.2. Europe Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 6.2.1. Key Highlights
  - 6.2.1.1. Normal saline
  - 6.2.1.2. Dextrose water
  - 6.2.1.3. Hydroxypropyl methylcellulose
  - 6.2.1.4. Hydroxyethyl starch
  - 6.2.1.5. Hyaluronic acid
  - 6.2.1.6. Fibrinogen mixture
  - 6.2.1.7. Succinylated gelatin
  - 6.2.1.8. Eleview and ORISE gel
6.3. Europe Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 6.3.1. Key Highlights
  - 6.3.1.1. Polyps
  - 6.3.1.2. Adenomas
  - 6.3.1.3. Early-stage Cancers
  - 6.3.1.4. Gastrointestinal Mucosal Lesions
  - 6.3.1.5. Others
6.4. Europe Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5. Europe Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 6.5.1. Key Highlights
  - 6.5.1.1. Germany Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.2. Germany Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.3. Germany Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.4. Germany Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.5. U.K. Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.6. U.K. Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.7. U.K. Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.8. U.K. Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.9. France Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.10. France Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.11. France Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.12. France Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.13. Italy Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.14. Italy Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.15. Italy Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.16. Italy Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.17. Turkey Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.18. Turkey Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.19. Turkey Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.20. Turkey Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.21. Russia Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.22. Russia Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.23. Russia Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.24. Russia Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.25. Rest of Europe Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.26. Rest of Europe Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.27. Rest of Europe Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 6.5.1.28. Rest of Europe Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Submucosal Lifting Agent Market Outlook, 2019 - 2032

7.1. Asia Pacific Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 7.1.1. Key Highlights
  - 7.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 7.1.1.2. Gellan gum and Polysaccharide
  - 7.1.1.3. Sodium Hyaluronate
  - 7.1.1.4. Cellulose
  - 7.1.1.5. Absorbable Starch Polymers
  - 7.1.1.6. Poloxamers
7.2. Asia Pacific Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 7.2.1. Key Highlights
  - 7.2.1.1. Normal saline
  - 7.2.1.2. Dextrose water
  - 7.2.1.3. Hydroxypropyl methylcellulose
  - 7.2.1.4. Hydroxyethyl starch
  - 7.2.1.5. Hyaluronic acid
  - 7.2.1.6. Fibrinogen mixture
  - 7.2.1.7. Succinylated gelatin
  - 7.2.1.8. Eleview and ORISE gel
7.3. Asia Pacific Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 7.3.1. Key Highlights
  - 7.3.1.1. Polyps
  - 7.3.1.2. Adenomas
  - 7.3.1.3. Early-stage Cancers
  - 7.3.1.4. Gastrointestinal Mucosal Lesions
  - 7.3.1.5. Others
7.4. Asia Pacific Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Specialty Clinics
  - 7.4.1.3. Surgical Centers
  - 7.4.1.4. Others
7.5. Asia Pacific Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 7.5.1. Key Highlights
  - 7.5.1.1. China Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.2. China Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.3. China Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.4. China Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.5. Japan Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.6. Japan Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.7. Japan Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.8. Japan Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.9. South Korea Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.10. South Korea Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.11. South Korea Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.12. South Korea Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.13. India Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.14. India Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.15. India Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.16. India Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.17. Southeast Asia Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.18. Southeast Asia Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.19. Southeast Asia Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.20. Southeast Asia Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.21. Rest of Asia Pacific Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.22. Rest of Asia Pacific Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.23. Rest of Asia Pacific Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 7.5.1.24. Rest of Asia Pacific Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Submucosal Lifting Agent Market Outlook, 2019 - 2032

8.1. Latin America Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 8.1.1. Key Highlights
  - 8.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 8.1.1.2. Gellan gum and Polysaccharide
  - 8.1.1.3. Sodium Hyaluronate
  - 8.1.1.4. Cellulose
  - 8.1.1.5. Absorbable Starch Polymers
  - 8.1.1.6. Poloxamers
8.2. Latin America Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3. Latin America Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 8.3.1. Key Highlights
  - 8.3.1.1. Polyps
  - 8.3.1.2. Adenomas
  - 8.3.1.3. Early-stage Cancers
  - 8.3.1.4. Gastrointestinal Mucosal Lesions
  - 8.3.1.5. Others
8.4. Latin America Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Specialty Clinics
  - 8.4.1.3. Surgical Centers
  - 8.4.1.4. Others
8.5. Latin America Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 8.5.1. Key Highlights
  - 8.5.1.1. Brazil Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.2. Brazil Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.3. Brazil Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.4. Brazil Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.5. Mexico Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.6. Mexico Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.7. Mexico Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.8. Mexico Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.9. Argentina Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.10. Argentina Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.11. Argentina Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.12. Argentina Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.13. Rest of Latin America Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.14. Rest of Latin America Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.15. Rest of Latin America Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 8.5.1.16. Rest of Latin America Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Submucosal Lifting Agent Market Outlook, 2019 - 2032

9.1. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 9.1.1. Key Highlights
  - 9.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
  - 9.1.1.2. Gellan gum and Polysaccharide
  - 9.1.1.3. Sodium Hyaluronate
  - 9.1.1.4. Cellulose
  - 9.1.1.5. Absorbable Starch Polymers
  - 9.1.1.6. Poloxamers
9.2. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 9.2.1. Key Highlights
  - 9.2.1.1. Normal saline
  - 9.2.1.2. Dextrose water
  - 9.2.1.3. Hydroxypropyl methylcellulose
  - 9.2.1.4. Hydroxyethyl starch
  - 9.2.1.5. Hyaluronic acid
  - 9.2.1.6. Fibrinogen mixture
  - 9.2.1.7. Succinylated gelatin
  - 9.2.1.8. Eleview and ORISE gel
9.3. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 9.3.1. Key Highlights
  - 9.3.1.1. Polyps
  - 9.3.1.2. Adenomas
  - 9.3.1.3. Early-stage Cancers
  - 9.3.1.4. Gastrointestinal Mucosal Lesions
  - 9.3.1.5. Others
9.4. Middle East & Africa Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 9.4.1. Key Highlights
  - 9.4.1.1. Hospitals
  - 9.4.1.2. Specialty Clinics
  - 9.4.1.3. Surgical Centers
  - 9.4.1.4. Others
9.5. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 9.5.1. Key Highlights
  - 9.5.1.1. GCC Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.2. GCC Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.3. GCC Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.4. GCC Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.5. South Africa Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.6. South Africa Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.7. South Africa Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.8. South Africa Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.9. Egypt Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.10. Egypt Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.11. Egypt Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.12. Egypt Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.13. Nigeria Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.14. Nigeria Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.15. Nigeria Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.16. Nigeria Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.17. Rest of Middle East & Africa Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.18. Rest of Middle East & Africa Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.19. Rest of Middle East & Africa Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  - 9.5.1.20. Rest of Middle East & Africa Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
- 9.5.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

10.1. Company Market Share Analysis, 2025
10.2. Competitive Dashboard
10.3. Company Profiles
- 10.3.1. Laborie
  - 10.3.1.1. Company Overview
  - 10.3.1.2. Product Portfolio
  - 10.3.1.3. Financial Overview
  - 10.3.1.4. Business Strategies and Development
- 10.3.2. STERIS
  - 10.3.2.1. Company Overview
  - 10.3.2.2. Product Portfolio
  - 10.3.2.3. Financial Overview
  - 10.3.2.4. Business Strategies and Development
- 10.3.3. Olympus America
  - 10.3.3.1. Company Overview
  - 10.3.3.2. Product Portfolio
  - 10.3.3.3. Financial Overview
  - 10.3.3.4. Business Strategies and Development
- 10.3.4. Medtronic
  - 10.3.4.1. Company Overview
  - 10.3.4.2. Product Portfolio
  - 10.3.4.3. Financial Overview
  - 10.3.4.4. Business Strategies and Development
- 10.3.5. Boston Scientific Corporation
  - 10.3.5.1. Company Overview
  - 10.3.5.2. Product Portfolio
  - 10.3.5.3. Financial Overview
  - 10.3.5.4. Business Strategies and Development
- 10.3.6. Omnimed Ltd
  - 10.3.6.1. Company Overview
  - 10.3.6.2. Product Portfolio
  - 10.3.6.3. Financial Overview
  - 10.3.6.4. Business Strategies and Development
- 10.3.7. COSMO PHARMACEUTICALS
  - 10.3.7.1. Company Overview
  - 10.3.7.2. Product Portfolio
  - 10.3.7.3. Financial Overview
  - 10.3.7.4. Business Strategies and Development
- 10.3.8. Ovesco Endoscopy AG
  - 10.3.8.1. Company Overview
  - 10.3.8.2. Product Portfolio
  - 10.3.8.3. Financial Overview
  - 10.3.8.4. Business Strategies and Development
- 10.3.9. Others
  - 10.3.9.1. Company Overview
  - 10.3.9.2. Product Portfolio
  - 10.3.9.3. Financial Overview
  - 10.3.9.4. Business Strategies and Development

11. Appendix

11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations